- Processing Solutions
- Agitators
- Asset Management
- Automation
- Blowers & Fans
- Centrifuges
- Chillers
- Compressors
- Conveyors
- Dryers & Evaporators
- Feeders
- Filtration & Separation
- Flowmeters
- Fluid Flow
- Heat Exchangers
- Instrumentation
- Level Measurement
- Maintenance & Safety
- Mixing & Blending
- Motors & Drives
- Oil Skimmers
- Piping & Tubing
- Packaging Equipment
- Powder & Bulk Solids
- Process Control
- Pumps & Seals
- Size Reduction
- Tanks & Vessels
- Valves & Actuators
- Weighing
- More
- Newsletters
- White Papers
- Buyer's Guide
- Videos
- Events
- Advertise
More
NEW YORK — The Carlyle Group, a global asset management firm, is in talks to acquire contract drug developer Pharmaceutical Product Development Inc. (PPD), Bloomberg reported.
Carlyle has edged out several other private-equity firms and entered into exclusive talks with the Wilmington, N.C.-based drug maker, the article stated.
PPD, which has a market cap of $3.5 billion, provides contract drug development and discovery services for pharmaceutical, biotechnology, medical device, academic and government organizations.
